Search clinical trials for: Relapsed Cancer
Total 88375 results
-
Ontario Clinical Oncology Group (OCOG)PfizerNot yet recruitingRefractory Multiple MyelomaCanada
-
Bristol-Myers SquibbNot yet recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States, Canada
-
Peter MacCallum Cancer Centre, AustraliaAbbVieNot yet recruitingRelapsed/Refractory Large B-cell LymphomaAustralia
-
Henan Cancer HospitalRecruitingExtensive Small Cell Lung CancerChina
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Karyopharm Therapeutics IncNot yet recruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Relapsed Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterKura Oncology, Inc.Not yet recruitingRefractory Acute Leukemia | Pediatric RelapsedUnited States
-
Tianjin Medical University Cancer Institute and...Nanjing Legend Biotech Co.Not yet recruitingB-Cell Non-Hodgkin Lymphoma-Recurrent | B-Cell Non-Hodgkin Lymphoma-RefractoryChina
-
Zhejiang UniversityNot yet recruitingRenal Cell Carcinoma | Nasopharyngeal Carcinoma | Ovarian Cancer | Cervix Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma | Metastatic Tumor
-
Delta-Fly Pharma, Inc.Not yet recruitingLeukemia, Myeloid, AcuteUnited States
-
Masonic Cancer Center, University of MinnesotaNot yet recruitingClassic Hodgkin Lymphoma | Autologous Stem Cell Transplant
-
Zhejiang Genfleet Therapeutics Co., Ltd.RecruitingLarge B-cell LymphomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingFollicular LymphomaChina
-
Byondis B.V.Not yet recruitingRelapsed / Refractory AML | Relapsed / Refractory MDS
-
Roswell Park Cancer InstituteRecruitingRecurrent Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Mantle Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell... and other conditionsUnited States
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
Peking University Cancer Hospital & InstituteRecruitingRelapsed/Refractory B-cell Non-Hodgkin LymphomaChina
-
National Cancer Institute (NCI)Not yet recruitingRecurrent Hairy Cell Leukemia | Recurrent Hairy Cell Leukemia Variant
-
Cartesian TherapeuticsRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Narendranath EpperlaNot yet recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory Mantle Cell Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid... and other conditionsUnited States
-
Inimmune CorporationAvance Clinical Pty Ltd.Not yet recruiting
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingMultiple MyelomaUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterRecruitingRefractory Acute Lymphoblastic Leukemia | Philadelphia-Negative ALL | Philadelphia-Positive ALL | Refractory Acute Lymphoblastic Leukemia (ALL) | Relapsed ALL, Adult | Refractory Acute Lymphoid Leukemia in RelapseUnited States
-
M.D. Anderson Cancer CenterNot yet recruitingB-cell Acute Lymphocytic Leukemia | Relapsed/RefractoryUnited States
-
Janssen-Cilag Ltd.RecruitingRelapsed/Refractory Multiple Myeloma (RRMM)France, Denmark, Israel, Spain, Italy, Germany, Sweden
-
Ryvu Therapeutics SARecruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic SyndromePoland
-
Atara BiotherapeuticsRecruitingHigh-grade B-cell Lymphoma | MCL | Diffuse Large B-cell Lymphoma (DLBCL) | Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | DLBCL/High-grade B-cell Lymphoma With MYC and BCL2 Rearrangements | Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma | LBCL With IRF4 Rearrangement | High-grade B-cell... and other conditionsUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaJapan
-
University Health Network, TorontoJanssen Inc.Not yet recruitingMultiple Myeloma | Relapsed Cancer | Refractory Cancer
-
M.D. Anderson Cancer CenterGlaxoSmithKlineRecruiting
-
Hua LiRecruitingPersonalized Cancer TreatmentChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Not yet recruitingRefractory Multiple Myeloma | Recurrent Multiple Myeloma
-
Georgetown UniversityMacroGenicsRecruitingExtensive-stage Small-cell Lung CancerUnited States
-
University of UtahRecruitingAcute Lymphoblastic Leukemia | Diffuse Large B Cell LymphomaUnited States
-
Uma BorateRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | Acute Myeloid Leukemia With KMT2A Rearrangement | Acute Myeloid Leukemia With NPM1 MutationUnited States
-
Hangzhou GluBio Pharmaceutical Co., Ltd.RecruitingNon-Hodgkin LymphomaChina
-
PfizerBristol-Myers SquibbRecruiting
-
M.D. Anderson Cancer CenterGenentech, Inc.; Kite, A Gilead CompanyRecruiting
-
British Columbia Cancer AgencyNot yet recruitingB-cell Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-Cell Leukemia | B-cell Acute Lymphoblastic Leukemia | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | High-grade B-cell LymphomaCanada
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Denmark, Sweden, China, Spain, Czechia, Poland, Australia, Netherlands, Argentina, Canada, United Kingdom, Greece, Brazil, India
-
University of ChicagoNot yet recruitingLymphoblastic Lymphoma | Acute Leukemia | Lymphoblastic LeukemiaUnited States
-
Daiichi SankyoMerck Sharp & Dohme LLCNot yet recruitingSmall Cell Lung CancerUnited States, Spain, Germany, Hungary, China, Italy, Korea, Republic of, United Kingdom, France, Belgium, Japan, Taiwan, Netherlands, Australia, Portugal, Poland, Turkey, Switzerland, Brazil, Canada, Romania
-
Elvira UmyarovaSanofiRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Huda SalmanRecruiting
-
Curon Biopharmaceutical (Shanghai) Co.,LtdRecruitingRelapsed or Refractory B-Cell Non-Hodgkin LymphomaChina
-
Chongqing Precision Biotech Co., LtdPeking University Cancer Hospital & InstituteRecruitingB Cell Lymphoma | Non Hodgkin LymphomaChina
-
BeBetter Med IncRecruitingRelapsed/Refractory Diffuse Large B-Cell LymphomaChina
-
CelgeneRecruitingMultiple MyelomaUnited States, Israel, Spain, Denmark, France, Germany, Netherlands
-
National Cancer Centre, SingaporeMerck Sharp & Dohme LLC; National Medical Research Council (NMRC), SingaporeNot yet recruitingRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaSingapore
-
Guangxi Medical UniversityNot yet recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | High Grade Serous Adenocarcinoma of OvaryChina
-
The First Affiliated Hospital of Xiamen UniversityThe First Affiliated Hospital with Nanjing Medical University; Shanxi Province... and other collaboratorsRecruitingFollicular Lymphoma | Relapsed Non-Hodgkin Lymphoma | Refractory B-Cell LymphomaChina